BioSkryb Genomics

📍 Durham, United States🗓 Founded 2018👥 62 employees💰 Last funded Dec 2019
Biotechnology Research🌐 bioskryb.com
Website LinkedIn
BioSkryb Genomics is a rapidly growing organization that is transforming single cell molecular discovery and analysis. Through its single cell whole genome and whole transcriptome amplification tools, scientists and clinicians can gain an unprecedented view of the genome, transcriptome, and proteome within a single cell to better understand the drivers, mechanisms, and management of complex disease. The company is headquartered in Durham, North Carolina. For more information, visit bioskryb.com.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2018
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in BioSkryb Genomics?
BioSkryb Genomics has 1 investors on record on gritt.io, including 1 early-stage backers.
When did BioSkryb Genomics last raise funding?
The most recent investment in BioSkryb Genomics recorded on gritt.io was in December 2019.
When was BioSkryb Genomics founded?
BioSkryb Genomics was founded in 2018.
What industry is BioSkryb Genomics in?
BioSkryb Genomics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is BioSkryb Genomics based?
BioSkryb Genomics is headquartered in Durham, United States.